As a prognostic marker, Ki-67 was used to differentiate luminal A and luminal B breast cancer molecular subtypes with a cutoff of 14%, which was changed to >20% in 2013 by the breast expert at the St Gallen International Breast Cancer Conference [24]. Here, MKI67 is linked to breast cancer.